| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |